array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Bio-RAD Laboratories, Inc." ["slug"]=> string(33) "001cd-us-bio-rad-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920" ["description"]=> string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together. #Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics" ["address_street"]=> string(20) "1000 Alfred Nobel Dr" ["address_place"]=> string(8) "Hercules" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1952-02-08" ["website_domain"]=> string(11) "bio-rad.com" ["website_url"]=> string(23) "https://www.bio-rad.com" ["industry_codes"]=> array(3) { [0]=> string(42) "In Vitro and In Vivo Diagnostic Substances" [1]=> string(33) "Laboratory Analytical Instruments" [2]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(7900) ["article_count"]=> int(659) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(97) "Hartford Investment Management Co. Has $452,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)" ["snippet_en"]=> string(249) "Hartford Investment Management Co. lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC)." ["url"]=> string(134) "https://www.defenseworld.net/2024/04/08/hartford-investment-management-co-has-452000-position-in-bio-rad-laboratories-inc-nysebio.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/90fd6be9-d94a-403b-9ecd-b42236ac8bbd" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2024-04-08" ["categories"]=> array(4) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(18) "General Investment" [2]=> string(9) "Valuation" [3]=> string(11) "Regulations" } } [1]=> array(7) { ["title_en"]=> string(90) "Tudor Investment Corp Et Al Invests $2.53 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)" ["snippet_en"]=> string(287) "Tudor Investment Corp Et Al purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 7,055 shares of the medical research company’s stock, valued at approximately $2,529,000." ["url"]=> string(129) "https://www.defenseworld.net/2024/03/14/tudor-investment-corp-et-al-invests-2-53-million-in-bio-rad-laboratories-inc-nysebio.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e1303b75-d719-46b0-9197-7c67e7b48c05" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2024-03-14" ["categories"]=> array(7) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(19) "Investment Requests" [3]=> string(13) "Credit Rating" [4]=> string(12) "Stock Market" [5]=> string(18) "General Investment" [6]=> string(24) "Quarterly/Annual Figures" } } [2]=> array(7) { ["title_en"]=> string(88) "Private Advisor Group LLC Has $234,000 Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)" ["snippet_en"]=> string(231) "Private Advisor Group LLC increased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 11.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission." ["url"]=> string(126) "https://www.defenseworld.net/2023/12/03/private-advisor-group-llc-has-234000-holdings-in-bio-rad-laboratories-inc-nysebio.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/22e3d56b-b7d5-4b29-a3d6-33ac65de01b1" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-12-03" ["categories"]=> array(6) { [0]=> string(11) "Regulations" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(20) "Corporate Governance" [3]=> string(18) "General Investment" [4]=> string(9) "Valuation" [5]=> string(11) "Acquisition" } } [3]=> array(7) { ["title_en"]=> string(66) "Bio-Rad Laboratories (BIO) Q3 Earnings and Revenues Miss Estimates" ["snippet_en"]=> string(188) "Bio-Rad (BIO) delivered earnings and revenue surprises of -18.82% and 8.47%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?" ["url"]=> string(73) "https://finance.yahoo.com/news/bio-rad-laboratories-bio-q3-214015742.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/54218d72-8d2f-496a-b2cb-e093122752ad" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-10-26" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Stock Market" [2]=> string(24) "Quarterly/Annual Figures" } } [4]=> array(7) { ["title_en"]=> string(52) "Bio-Rad Shares Drop After Company Reports 3Q Results" ["snippet_en"]=> string(160) "By Stephen Nakrosis Shares of Bio-Rad Laboratories were trading lower in the after-hours market following the release of third-quarter financial results that..." ["url"]=> string(95) "https://www.marketwatch.com/story/bio-rad-shares-drop-after-company-reports-3q-results-0d9c70ab" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3bebe02f-4333-46c5-bde4-e8e5d9bb24c2" ["source"]=> string(15) "marketwatch.com" ["publication_date"]=> string(10) "2023-10-26" ["categories"]=> array(7) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(15) "Market Movement" [2]=> string(14) "Issuing Shares" [3]=> string(31) "Financial Update/Profit Warning" [4]=> string(21) "Financial Performance" [5]=> string(12) "Stock Market" [6]=> string(24) "Quarterly/Annual Figures" } } [5]=> array(7) { ["title_en"]=> string(84) "Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023" ["snippet_en"]=> string(150) "Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, will report its financial" ["url"]=> string(140) "https://www.businesswire.com/news/home/20231005466163/en/Bio-Rad-to-Report-Third-Quarter-2023-Financial-Results-on-Thursday-October-26-2023/" ["image_url"]=> NULL ["source"]=> string(16) "businesswire.com" ["publication_date"]=> string(10) "2023-10-05" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [6]=> array(7) { ["title_en"]=> string(125) "S&P 500 paper Bio-Rad Laboratories share: This is how much profit an early Bio-Rad Laboratories investment would have brought" ["snippet_en"]=> string(88) "Invested in Bio-Rad Laboratories years ago: That's how much investors would have earned." ["url"]=> string(174) "https://www.finanzen.ch/nachrichten/aktien/s-p-500-papier-bio-rad-laboratories-aktie-so-viel-gewinn-haette-eine-fruehe-bio-rad-laboratories-investition-eingebracht-1032637282" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c88e0eed-05ab-4928-82b1-85b90a42b1f2" ["source"]=> string(11) "finanzen.ch" ["publication_date"]=> string(10) "2023-09-18" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Stock Market" [2]=> string(18) "General Investment" } } [7]=> array(7) { ["title_en"]=> string(121) "S&P 500 value Bio-Rad Laboratories share: This is how much an early investment in Bio-Rad Laboratories would have yielded" ["snippet_en"]=> string(103) "If investors had invested in Bio-Rad Laboratories shares early on, they would have made so much profit." ["url"]=> string(167) "https://www.finanzen.ch/nachrichten/aktien/s-p-500-wert-bio-rad-laboratories-aktie-so-viel-haette-eine-fruehe-investition-in-bio-rad-laboratories-abgeworfen-1032620337" ["image_url"]=> string(78) "https://images.businessradar.com/articles/9f6a2e34-28ab-48f5-8c68-aad3cf187869" ["source"]=> string(11) "finanzen.ch" ["publication_date"]=> string(10) "2023-09-11" ["categories"]=> array(4) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Stock Market" [2]=> string(14) "Issuing Shares" [3]=> string(18) "General Investment" } } [8]=> array(7) { ["title_en"]=> string(128) "S&P 500 paper Bio-Rad Laboratories stock: This is how much profit an early investment in Bio-Rad Laboratories would have yielded" ["snippet_en"]=> string(85) "Got into Bio-Rad Laboratories years ago: That's how much investors would have earned." ["url"]=> string(176) "https://www.finanzen.ch/nachrichten/aktien/s-p-500-papier-bio-rad-laboratories-aktie-so-viel-gewinn-haette-ein-fruehes-investment-in-bio-rad-laboratories-eingefahren-1032551788" ["image_url"]=> string(78) "https://images.businessradar.com/articles/232e62ff-2bf0-4212-9b24-2f54b5a252e6" ["source"]=> string(11) "finanzen.ch" ["publication_date"]=> string(10) "2023-08-14" ["categories"]=> array(4) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(12) "Stock Market" [3]=> string(18) "General Investment" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(66) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(51) } [2]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(31) } [3]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(28) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(26) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(23) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(20) } [8]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(19) } [9]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(19) } [11]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(18) } [12]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [14]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(13) } [15]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(13) } [16]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(9) } [19]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [20]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(8) } [21]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(7) } [24]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(7) } [25]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(5) } } } 001cd-us-bio-rad-laboratories-inc